相关实验视频
Updated: May 8, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.3K
适应性多核图神经网络用于药物相互作用预测.
Linqian Zhao1, Junliang Shang2, Xianghan Meng1
1School of Computer Science, Qufu Normal University, Rizhao, 276826, China.
Interdisciplinary sciences, computational life sciences
|January 28, 2025
概括
预测药物相互作用 (DDI) 对患者安全至关重要. 一个新的自适应多核图神经网络 (AMKGNN) 模型准确地区分了DDI类型,提高了预测准确度和预防药物不良反应.
科学领域:
- 药理学和计算生物学
- 药物发现和开发 药物发现和开发
背景情况:
- 组合疗法可以提高治疗效果,但会带来不良药物相互作用 (DDI) 的风险.
- 当前的DDI预测模型经常忽视特定的交互类型,影响准确性.
- 准确的DDI预测对于药物安全性和理解机制至关重要.
研究的目的:
- 通过考虑相互作用类型,开发一种先进的模型来预测药物相互作用 (DDI).
- 提高DDI预测方法的准确性和可靠性.
主要方法:
- 提出了一个自适应的多核图形神经网络 (AMKGNN) 模型.
- 将DDI分为增加型和减少型相互作用,创建单独的图表.
- 采用图核学习来自适应地确定节点嵌入的信号值.
- 集成的药物嵌入与各种药物特征用于使用深度神经网络进行预测.
主要成果:
- 在两个数据集上的三个子任务中,AUC和AUPR值超过了90%.
- 在DDI预测中明显优于其他五种比较模型.
- 废弃实验和案例研究证实了AMKGNN模型的优越性.
结论:
- 通过区分相互作用类型,AMKGNN模型在预测DDI方面表现出卓越的性能.
- 这种方法提高了对药物机制的理解,并有助于预防不良药物事件.
- 该模型为改善临床实践中药物安全提供了一个有希望的工具.
相关概念视频
Agonism and Antagonism: Quantification
254
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
254
Combined Effects of Drugs: Antagonism
8.1K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.1K
Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
Drug-Receptor Interactions
4.6K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
4.6K
Drug-Receptor Interaction: Antagonist
2.5K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.5K
Protein-protein Interfaces
12.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.4K

